Kilroy Conor 4

What Happened

• Conor Kilroy, Chief Legal Officer and Secretary of Aura Biosciences (AURA), sold 12,079 shares in a disposition reported on 2026-02-17. The weighted average price was $5.05 per share (range $5.04–$5.25), for total proceeds of about $60,999.
• The sale was automatic to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs), not an open discretionary trade.

Key Details

• Transaction date: 2026-02-17. Transaction type: Sale (S); purpose: tax withholding for RSU vesting (footnote).
• Shares sold: 12,079 at a weighted average price of $5.05; prices ranged from $5.04 to $5.25 across multiple trades. Total proceeds ≈ $60,999. (Reporting person can provide per-trade breakdown on request.)
• Shares owned after the transaction: Not disclosed on this Form 4.
• Footnotes: F1 confirms sales were automatic to cover tax withholding; F2 explains the reported price is a weighted average across multiple transactions and offers additional breakdown on request.
• Filing timeliness: Form filed with a report period of 2026-02-17 and accession date 2026-02-17; no late filing indicated.

Context

• Tax-withholding sales tied to RSU vesting are routine and generally aimed at meeting tax obligations rather than signaling a deliberate sell decision about the company. For retail investors, purchases typically carry more weight as a positive signal; automatic tax-sales are common and not necessarily informative about insider sentiment.